Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis
T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France)
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Session: Pulmonary fibrosis: from models to patients
Session type: Thematic Poster
Number: 992
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France). Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis. 992
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: